HYPOLIPIDEMIC MEDICATIONS: CURRENT USE AND FUTURE PERSPECTIVES. PART 3. STATIN’S USING IN DIFFERENT PATIENT’S CATEGORY
This article is devoted to discussion about statin’s using in patients with atherosclerosis-associated disease, arterial hypertension, diabetes mellitus, chronic kidney disease, familial hypercholesterolaemia, rheumatoid arthritis, systemic lupus erythematosus, nonalcoholic fatty liver disease and g...
Main Authors: | A. E. Bagriy, A. I. Dyadyk, M. V. Khomenko, I. N. Tsiba, V. A. Efremenko, E. V. Schukina, O. A. Prikolota |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Siberian Branch of Russian Academy of Sciences, Research Institute of Internal and Preventive Medicine, branch of the Institute of Cytology and Genetics
2016-09-01
|
Series: | Атеросклероз |
Subjects: | |
Online Access: | https://ateroskleroz.elpub.ru/jour/article/view/23/23 |
Similar Items
-
HYPOLIPIDEMIC MEDICATIONS: CURRENT USE AND FUTURE PERSPECTIVES. PART 2. A COMMON APPROACHES FOR STATIN’S USING
by: A. E. Bagriy, et al.
Published: (2016-06-01) -
HYPOLIPIDEMIC MEDICATIONS: CURRENT USE AND FUTURE PERSPECTIVES. PART 1. NON-STATIN HYPOLIPIDEMIC MEDICATIONS
by: A. E. Bagriy, et al.
Published: (2016-03-01) -
Statins: have we found the Holy Grail?
by: Raban Jeger, et al.
Published: (2012-01-01) -
Familial Hypercholesterolaemia as a Predisposing Factor for Atherosclerosis
by: Anastasia V. Poznyak, et al.
Published: (2022-10-01) -
Overview of a collaborative global effort to address the burden of familial hypercholesterolaemia
by: Alexander R.M. Lyons, et al.
Published: (2024-03-01)